Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 368 (LINC00368)
- Target
- LINC00368
- Molecular classification
- Long non-coding RNA, Long intergenic non-coding RNA (lincRNA), Other
01
Overview
Long intergenic non-protein coding RNA 368 (LINC00368) is a type of long intergenic non-coding RNA (lincRNA), meaning it is a non-protein-coding transcript over 200 nucleotides in length that does not overlap protein-coding genes[1][3]. LINC00368 belongs to the broader class of long non-coding RNAs, which can regulate gene expression through mechanisms such as chromatin remodeling, transcriptional and post-transcriptional regulation, and modulation of nuclear architecture[3][5][7]. Expression and function of specific lincRNAs—including LINC00368—are still under investigation, but lincRNAs in general are increasingly recognized as molecular regulators and potential biomarkers in cancer and other diseases[1][5][7]. There is no evidence that LINC00368 is itself a receptor, enzyme, transporter, or other direct therapeutic drug target; rather, it may regulate disease processes at the RNA level[1][3][7].
- Other names
- LINC00368Long intergenic non-coding RNA 368
02
Biological functions
Gene expression regulationEpigenetic regulationPost-transcriptional regulationOther
03
Disease associations
CancerOther (roles are emerging and incompletely characterized)
04
Biomarkers
Potential biomarker for cancer classification or prognosis (based on emerging lncRNA evidence in cancer)
Beyond the preview
Go deeper on Long intergenic non-protein coding RNA 368 (LINC00368).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Long intergenic non-protein coding RNA 368 (LINC00368).